Share
CNBC Pro

Watch CNBC's full interview with Pfizer CEO Albert Bourla

Albert Bourla, chairman and CEO of Pfizer, joins "Squawk on the Street" to discuss the company's trials of a Covid-19 vaccine and when he expects to see it ready for FDA approval. Right now, we do expect—we have a very good chance of having a conclusive efficacy of phase 3 before the end of October, he says. You need to see a statistically significant difference between between the control arm that are getting the placebo and the vaccinated arm, adds Bourla.
06:43
Mon, Sep 14 202011:20 AM EDT

watch now
VIDEO22:42
CNBC ProWatch Friday's full episode of Fast Money — April 9, 2021
watch now
VIDEO04:12
CNBC ProEarnings are strong and will remain strong, according to US Bank Wealth Management
watch now
VIDEO44:02
CNBC ProWatch Friday's full episode of the Halftime Report — April 9, 2021
watch now
VIDEO05:32
CNBC ProHow surging inflation may cause economic risks, according to an economist
watch now
VIDEO13:07
CNBC ProHow Morgan Creek's Mark Yusko is investing right now